Diversity in Lilly-Sponsored Clinical Trials in North America
To gain greater insight into the effectiveness of potential medicines across a diverse population, we work to increase minority participation in our clinical trials. Our goal is that every study conducted with more than 25 clinical trial sites must select at least two sites meeting Lilly’s diversity criteria.
A diverse clinical trial site means the patient population is greater than 25 percent non-Caucasian. Since we began focusing on increasing minority participation in clinical trials, we have added more than 400 new clinical trial sites with minority patient populations of more than 25 percent.